Deep Track Capital, LP Spring Works Therapeutics, Inc. Transaction History
Deep Track Capital, LP
- $2.27 Billion
- Q4 2024
A detailed history of Deep Track Capital, LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 3,460,756 shares of SWTX stock, worth $172 Million. This represents 5.51% of its overall portfolio holdings.
Number of Shares
3,460,756
Previous 3,843,900
9.97%
Holding current value
$172 Million
Previous $123 Million
1.53%
% of portfolio
5.51%
Previous 4.54%
Shares
9 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$356 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$280 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$163 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$149 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx2.89MShares$144 Million2.02% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.11B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...